Effects of Vestibular Stimulation in Addition to Conventional Physiotherapy in Improving Gross Motor Function and Mobility in Children With Spastic Diplegic Cerebral Palsy

This was a RCT to determine and compare the effects of vestibular stimulation in addition to conventional physical therapy on gross motor function and mobility in children with spastic diplegic cerebral palsy.

Study Overview

• Status: Completed
• Conditions: Spastic Diplegic Cerebral Palsy
• Intervention / Treatment: Other: Experimental Group A received Vestibular Stimulation along with Conventional therapy.; Other: Control Group B received Conventional physiotherapy alone.

Detailed Description

In this RCT , Experimental Group received Vestibular Stimulation along with Conventional therapy. Control Group received Conventional physiotherapy alone.

• Study Type: Interventional
• Enrollment (Actual): 58
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Pakistan
  • KPK
    • Mansehra, KPK, Pakistan, 25000
      • Ibadat International University, Islamabad

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• • Participants with age limit of 6-12 years

  • Diagnosed cases of Spastic Diplegic Cerebral Palsy by Pediatric neurologist
  • Both genders (male/female)
  • Participants with GMFCS Level I-III
  • Participants with Grade I spasticity, Modified Ashworth Scale (MAS) • Participants able to understand and follow basic commands.

Exclusion Criteria:

• • Children with history of vestibular disorders, epileptic fits or uncontrolled seizures from past six months

  • Children with any surgical procedure of the spine or lower limbs or Botox treatment in the last 6 months
  • Children with any visual or hearing impairment
  • Children having any fixed deformity, contracture or fracture limiting participation in therapy
  • Patients having VP shunt

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Experimental Group A received Vestibular Stimulation along with Conventional therapy.; Participants in this group received Vestibular Stimulation along with Conventional therapy.	Other: Experimental Group A received Vestibular Stimulation along with Conventional therapy.; Experimental Group A received Vestibular Stimulation along with Conventional therapy. Vestibular stimulation included Multi-directional swinging , Trampoline jumps , Rocking movement , Gaze stabilization exercises , Visual pursuit exercises , Passive soft tissue stretching , Lower limb resistance exercises , Balance board training , Movement transitions.
Active Comparator: Control Group B received Conventional physiotherapy alone.; Participants in this group received Conventional physiotherapy alone	Other: Control Group B received Conventional physiotherapy alone.; Control Group B received Conventional physiotherapy alone which includes Passive soft tissue stretching , Lower limb resistance exercises , Balance board training , Movement transitions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Gross Motor Function Measure (GMFM-88)	Gross Motor Function Measure (GMFM-88) will be used to assess the progression of gross motor function over time in cerebral palsy affected children. The original GMFM version has 88-items and divided into five dimensions. each item scored on a 4-point ordinal scale of 0 to 3, where: 0 shows that the participant does not begin the activity; 1 show that the participant initiates the activity (completes < 10% of the activity); 2 show that the participant completes the activity partially (performed from 10 to 99% of the activity); 3 show that the participant finishes the activity (100%); NT show that the participant was not tested For each item, maximum of three trials is permitted and the best one will be recorded. Scores for each group are expressed as a percentage of the its highest score and the total score is calculated by summing the percentage scores for each of the five groups/dimensions.	Assessment was performed at baseline and after 6 weeks of intervention.
10-Meter Walk Test (10MWT)	The 10 Meter Walk Test was used to determine functional mobility in children with spastic diplegic cerebral palsy. The test will be conducted on a 14 m pathway, including the starting and ending points, with a 2 m walk-in section. The time taken to reach the midpoint of the 10 m walk will be recorded.	Assessment was performed at baseline and after 6 weeks of intervention
Timed Up and Go (TUG) test	Mobility of children was evaluated via timed get up and go (TUG) test and its results were recorded.(15) In this test, the duration of standing up from an armchair, walking up to 3 m, turn walk back, and sitting on the chair was measured. (16) Interpretations are as follow: <10 seconds = normal; < 20 seconds = good mobility, can go out alone, mobile without a gait aid.; < 30 seconds = problems, cannot go outside alone, requires a gait aid.	Assessment was performed at baseline and after 6 weeks of intervention.

Collaborators and Investigators

• Sponsor: Ibadat International University, Islamabad

Study record dates

Study Major Dates

• Study Start (Actual): January 11, 2026
• Primary Completion (Actual): June 30, 2026
• Study Completion (Actual): July 3, 2026

Study Registration Dates

• First Submitted: July 14, 2026
• First Submitted That Met QC Criteria: July 14, 2026
• First Posted (Actual): July 17, 2026

Study Record Updates

• Last Update Posted (Actual): July 17, 2026
• Last Update Submitted That Met QC Criteria: July 14, 2026
• Last Verified: July 1, 2026

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Brain Damage, Chronic; Cerebral Palsy
• Other Study ID Numbers: IIUI/RERC/ADT/2026/01/215

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No